NMOSD and MOGAD Clinical Trials

Siegel Rare Neuroimmune Association

M. Levy

MS DMTs: Infection Risks and Vaccination Considerations

Sarah Conway

MS Disease Modifying Therapies: A Case Based Approach

OhioHealth

P. Sutton

Multiple Sclerosis Treatment

ZINCARE

M. Chomba

Strategies to Promote Myelin Repair

OHSU

L. Wooliscroft

Multiple Sclerosis for the Non-Neurologist

Providence Swedish

J. D. Bowen

Aberrant Iron Deposition in the Progressive MS Spinal Cord Relates t…

Marco Pisa

ECTRIMS 2024 Insights: Increased Brain Age Is Associated With Clinic…

Lonneke Bos

COVID-19 & Multiple Sclerosis: Can Immunosuppressive Therapy Decreas…

Gavin Giovannoni

Neurological Reserve in Multiple Sclerosis: Concepts, Metrics, and P…

University at Buffalo Neurology Department

R. H.B. Benedict

ECTRIMS 2024 Insights: Pathology of NMOSD, MOGAD and MS

Hans Lassmann

The Role of B Cells in Progressive MS and the Long-term Effects of B…

The France Foundation

J. Berger

Use of Advanced Imaging and AI in Diagnosis and Treatment of Multipl…

Houston Methodist

A. R. Alchaki

ECTRIMS 2024 Insights: Role of Diet, Vitamins and in MS

Anneke Van Der Walt

ECTRIMS 2024 Insights: Clinical Spectrum of MOG Antibody-Associated …

Kazuo Fujihara

Breaking Down Common But Complicated Questions in MS: Updates on Bio…

Women Neurologists Group (WNG)

E. M. Schorr

The Connection Between Viruses and Other Factors Contributing to the…

The France Foundation

M. Levy

Effectiveness of Tixagevimab/Cilgavimab (Evusheld) in AntiCD20-Treat…

Dominika Stastna

Neural effects of fatigue on cognition in relapsing MS detected by m…

2023 Conference Coverage

A. Memon

Inflammatory Management in Multiple Sclerosis, The Complementary Med…

Women Neurologists Group (WNG)

M. Rensel